Skip to main content
Masimo Logo
  • Overview
    • Company Profile
    • News
    • Events & Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Annual Reports
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Committee Composition
    • Resources
      • Information Request Form
      • Investor Emails Alerts
      • Investor Contacts
Toggle navigation Menu

SEARCH

×

News

  • Overview
    • Company Profile
    • News
    • Events & Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Annual Reports
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Committee Composition
    • Resources
      • Information Request Form
      • Investor Emails Alerts
      • Investor Contacts

×

Normal
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
12/12/2018
Masimo Founder and CEO Joe Kiani Honored with First IP Champion Award
11/12/2018
International Consensus Statement on Postoperative Anemia Management Recommends Noninvasive Hemoglobin Measurement Including Masimo SpHb®
11/07/2018
Masimo to Present at Stifel 2018 Healthcare Conference
10/31/2018
Masimo Reports Third Quarter 2018 Financial Results
10/25/2018
Masimo Announces FDA Clearance for Masimo RD Sensors with Improved Accuracy Specifications for SET® Pulse Oximetry
10/17/2018
Masimo to Report Third Quarter 2018 Financial Results after Market Close on Wednesday, October 31
10/17/2018
Bassett Medical Center of New York Adopts Masimo Patient SafetyNet™ and Root® with Vital Signs Check
10/01/2018
New Study Evaluates the Ability of Masimo ORi™ to Help Clinicians Reduce Hyperoxemia in Mechanically Ventilated ICU Patients
09/10/2018
Masimo to Present at Morgan Stanley 16th Annual Global Healthcare Conference
09/10/2018
Masimo Announces FDA Clearance of the rainbow Acoustic Monitoring® RAS-45 Sensor for Infant and Neonatal Patients
09/05/2018
New Study Compares Two Methods of Guiding Goal-Directed Fluid Therapy, Noninvasive Masimo PVi® and Invasive Esophageal Doppler
08/27/2018
New Study Evaluates the Ability of Masimo ORi™ to Reflect Oxygenation During Moderate Hyperoxia
08/13/2018
New Study Investigates the Utility of Home Monitoring Using Masimo SET® Pulse Oximetry to Screen Children with Down Syndrome for Risk of Obstructive Sleep Apnea Prior to Diagnostic Multichannel Sleep Studies
08/02/2018
H Michael Cohen Joins Masimo’s Board of Directors
08/01/2018
Masimo Reports Second Quarter 2018 Financial Results and Announces Board Authorization of a New Stock Repurchase Program
07/26/2018
New Study Investigates Impact of General Ward Clinical Monitoring Using Masimo Root®, Radius-7®, and Patient SafetyNet™ on Clinical Workflow and Patient Care
07/18/2018
Masimo to Report Second Quarter 2018 Financial Results after Market Close on Wednesday, August 1
07/16/2018
New Study Investigates the Utility of Masimo PVi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery
07/09/2018
Masimo Announces Vital Signs Check Application for the Root® Patient Monitoring and Connectivity Platform
07/01/2018
New Study Investigates the Utility of Masimo ORi™ (Oxygen Reserve Index) in Providing Early Detection of Blood Oxygenation Decrease During One-Lung Ventilation
06/26/2018
United Arab Emirates Ministry of Health & Prevention Adopts National CCHD Newborn Screening Program Using Masimo Rad-97™ Pulse CO-Oximeters® with Eve™
06/18/2018
Masimo and PositiveID Announce the U.S. Release of TIR-1™
06/11/2018
New Study Investigates the Utility of Masimo SedLine® Patient State Index in Monitoring Anesthesia Depth of Patients with Healthy and Cirrhotic Livers
06/04/2018
New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement With Masimo SpHb® for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration
05/21/2018
Women’s Tennis Association to Use Masimo MightySat™ Fingertip Pulse Oximeters to Advance Player Health and Performance
05/14/2018
New Study Investigates the Economic Impact and Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb® in Reducing Unnecessary Blood Transfusions
05/07/2018
Masimo SET® Pulse Oximetry Helps Form Basis of Utah Senate Resolution on Postoperative Oxygen Saturation Home Monitoring for Patients Prescribed Opioids
05/02/2018
Masimo Reports First Quarter 2018 Financial Results
05/01/2018
Masimo to Present at Deutsche Bank 43rd Annual Health Care Conference
05/01/2018
Masimo O3® Regional Oximetry and SedLine® Brain Function Monitoring Power Two Investigations into Postoperative Delirium Presented at IARS
04/19/2018
New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices
04/18/2018
Masimo to Report First Quarter 2018 Financial Results after Market Close on Wednesday, May 2
04/10/2018
Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® with Integrated NomoLine™ Capnography
04/02/2018
Masimo Announces UniView™
03/12/2018
New Study Investigates the Performance of Masimo SpHb® During Acute Bleeding and After Fluid Resuscitation
03/07/2018
Masimo to Present at Barclays Global Healthcare Conference
03/06/2018
Masimo Announces Replica™
03/01/2018
Masimo to Present at 39th Annual Raymond James Institutional Investors Conference
02/27/2018
Masimo Reports Fourth Quarter 2017 Financial Results
02/26/2018
Leading Nephrology Care Center in India Adopts Masimo Technologies Across Continuum of Care
02/22/2018
New Study Evaluates the Performance of Masimo SpHb® in Monitoring Pediatric Trauma Patients
02/12/2018
New Study Evaluates the Performance of Masimo PVi® as a Predictor of Fluid Responsiveness in Mechanically Ventilated ICU Patients
02/07/2018
Masimo Announces CE Marking of Eve™ CCHD Newborn Screening Application for the Rad-97™ Pulse CO-Oximeter®
01/30/2018
Masimo to Report Fourth Quarter and Full Year 2017 Financial Results after Market Close on Tuesday, February 27
01/29/2018
Masimo Announces FDA Clearance of Next Generation SedLine® Brain Function Monitoring
01/22/2018
New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients
01/09/2018
Masimo Announces FDA Clearance for Home Use of Rad-97™
01/03/2018
Masimo to Present at 36th Annual J.P. Morgan Healthcare Conference
01/02/2018
Masimo Announces CE Marking and Release of Oxygen Reserve Index™ rainbow Lite Sensors
Masimo Logo

Follow us

Privacy

Privacy Notice

Cookie Notice

Resources

Information Request Email Alerts
© Masimo. All Rights Reserved.
Powered By Q4 Inc. 5.86.0.1 (opens in new window)